Percutaneous Coronary Intervention clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
open to eligible people ages 18 years and up
To test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease.
at UCLA UCSD
Last updated: